Mithra Pharmaceuticals S.A.
A biotech company developing drugs for contraception, fertility, and menopause.
MITRA | BR
Overview
Corporate Details
- ISIN(s):
- BE0974283153 (+1 more)
- LEI:
- 5493002FDD273HTEKK14
- Country:
- Belgium
- Address:
- Rue Saint-Georges 5, 4000 Liège
- Website:
- https://www.mithra.com/
- Sector:
- Manufacturing
Description
Mithra Pharmaceuticals S.A. is a biotech company dedicated to women's health. The company focuses on the development, manufacturing, and commercialization of differentiated drugs and complex therapeutic solutions. Its core areas of expertise include contraception, fertility, and menopause. Mithra aims to transform the women's health sector by providing innovative choices to support and improve the overall quality of life for women.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-10-05 07:30 |
2018-10-05-Explanatory-Note-EN.pdf
|
English | 139.0 KB | ||
| 2018-10-05 07:30 |
2018-10-05-Notice-FR.pdf
|
French | 214.9 KB | ||
| 2018-10-05 07:30 |
2018-10-05-COMM WARRANT PLAN-EN.pdf
|
English | 295.6 KB | ||
| 2018-10-05 07:30 |
2018-10-05-COMM WARRANT PLAN-FR.pdf
|
French | 300.2 KB | ||
| 2018-09-25 07:30 |
MITHRA ANNOUNCES 2018 HALF YEAR RESULTS
|
English | 656.5 KB | ||
| 2018-09-25 07:30 |
MITHRA ANNONCE SES RÉSULTATS SEMESTRIELS 2018
|
French | 604.5 KB | ||
| 2018-09-25 07:30 |
First half 2018 financial report-final-EN.pdf
|
English | 1013.0 KB | ||
| 2018-09-25 07:30 |
First half 2018 financial report-final-FR.pdf
|
French | 1.1 MB | ||
| 2018-09-12 11:45 |
20180912-Press conference Estelle GR.pdf
|
English | 499.8 KB | ||
| 2018-09-12 11:45 |
MITHRA ANNOUNCES FURTHER DETAILS REGARDING CONTRACT GEDEON RICHTER
|
English | 288.6 KB | ||
| 2018-09-12 07:28 |
MITHRA AND RICHTER SIGN LICENSE AND SUPPLY AGREEMENT FOR COMMERCIALIZATION OF E…
|
English | 307.7 KB | ||
| 2018-09-12 07:28 |
MITHRA ET RICHTER SIGNENT UN ACCORD DE LICENCE ET D’APPROVISIONNEMENT POUR LA C…
|
French | 307.4 KB | ||
| 2018-08-08 07:30 |
MITHRA ANNOUNCES POSITIVE TOP-LINE RESULTS OF ESTELLE® PHASE III ORAL CONTRACEP…
|
English | 411.7 KB | ||
| 2018-08-08 07:30 |
MITHRA ANNONCE DES PREMIERS RÉSULTATS POSITIFS POUR L’ÉTUDE DE PHASE III CONSAC…
|
French | 417.6 KB | ||
| 2018-07-30 07:30 |
MITHRA ANNOUNCES BELUX1 AGREEMENT WITH CERES PHARMA WORTH OVER EUR 40 MILLION
|
English | 348.6 KB |
Automate Your Workflow. Get a real-time feed of all Mithra Pharmaceuticals S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mithra Pharmaceuticals S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mithra Pharmaceuticals S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | NOSHAQ SA | Board | Other | 172,574 | 617,814.92 EUR |
| 2022-11-17 | NOSHAQ SA | Board | Other | 172,574 | 1,052,701.40 EUR |
| 2022-07-18 | NOSHAQ SA | Board | Other | 156,250 | 1,006,250.00 EUR |
| 2022-05-13 | NOSHAQ SA | Board | Other | 156,250 | 1,239,062.50 EUR |
| 2022-04-13 | Gordenne Valérie | Other | Sell | 8,500 | 87,380.00 EUR |
| 2022-03-29 | Fornieri Francesco | Board | Sell | 100,000 | 1,312,000.00 EUR |
| 2022-03-25 | Fornieri Francesco | Board | Sell | 35,893 | 486,530.57 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 15,657 | 219,536.19 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 2,818 | 39,452.00 EUR |
| 2022-03-23 | Fornieri Francesco | Board | Sell | 12,525 | 178,230.75 EUR |
Peer Companies
